# Pimavanserin Tartrate (Nuplazid)

Source: https://ourhealthnetwork.com/drugs/pimavanserin-tartrate
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Pimavanserin Tartrate?

Pimavanserin Tartrate (brand name: Nuplazid) is an atypical antipsychotic. It is prescribed to treat parkinson disease, hallucinations. Across the United States, 4,000 doctors prescribe Pimavanserin to approximately 3,000 Medicare patients.

## Brand names

Nuplazid

## Indications

Pimavanserin Tartrate is prescribed for the treatment of parkinson disease and hallucinations.

## Conditions treated

- [Parkinson Disease](https://ourhealthnetwork.com/conditions/parkinson-disease)
- [Hallucinations](https://ourhealthnetwork.com/conditions/hallucinations)

## Mechanism of action

The mechanism of action of pimavanserin in the treatment of hallucinations and delusions associated with PDP is unclear. However, the effect of pimavanserin could be mediated through a combination of inverse agonist and antagonist activity at serotonin 5-HT 2A receptors and to a lesser extent at serotonin 5-HT 2C receptors.

## Drug classification

- Established Pharmacologic Class: atypical antipsychotics
- Route of administration: ORAL

## Common side effects

confusion, edema, fatigue, infection, peripheral edema, urinary tract infection

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)